Varicella-Zoster Virus Infection | Poland| PDF | PPT| Case Reports | Symptoms | Treatment

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Varicella-Zoster Virus Infection

  • Varicella-Zoster Virus Infection

    Pathophysiology: Little is known about the route and the source of transmission of the virus. VZV is certainly transmissible through the airborne route and does not require close personal contact. The skin lesions are certainly full of infectious virus particles whilst in contrast, it is almost impossible to isolate virus from the upper respiratory tract. It is possible that aerial transmission originates from symptomless oral lesions.

  • Varicella-Zoster Virus Infection

    Disease statistics: Review admissions to Infectious Disease Hospital 65% of 1690 hospital admissions were due to VZV infection (91% varicella and 9% HZ. Mean age 33 years, range 3 days to 94 years; 69% were 11-40 years.

  • Varicella-Zoster Virus Infection

    Treatment: Several studies indicate that antiviral medications decrease the duration of symptoms and the likelihood of postherpetic neuralgia, especially when initiated within 2 days of the onset of rash. In typical cases that involve individuals who are otherwise healthy, oral acyclovir may be prescribed.

  • Varicella-Zoster Virus Infection

    Research: Seroprevalence of varicella-zoster virus in Polish population

Expert PPTs
Speaker PPTs

High Impact List of Articles

Conference Proceedings